SABBY MANAGEMENT, LLC - Q3 2016 holdings

$2.67 Billion is the total value of SABBY MANAGEMENT, LLC's 307 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 113.5% .

 Value Shares↓ Weighting
BuySPDR S&P 500 ETF TRUSTput$302,820,000
+71.7%
14,000
+66.4%
11.34%
+23.3%
NewSPDR S&P 500 ETF TRUSTcall$216,300,00010,000
+100.0%
8.10%
NewISHARES RUSSELL 2000put$184,973,00014,892
+100.0%
6.93%
NewGILEAD SCIENCES INCcall$92,499,00011,691
+100.0%
3.46%
BuyREGENERON PHARMACEUTICALS INCput$72,042,000
+77.8%
1,792
+54.5%
2.70%
+27.7%
NewISHARES RUSSELL 2000call$67,583,0005,441
+100.0%
2.53%
BuyMONSANTO COcall$57,304,000
+3.9%
5,607
+5.1%
2.15%
-25.4%
NewAMGEN INCput$42,853,0002,569
+100.0%
1.60%
BuyELI LILLY & COput$39,311,000
+2.1%
4,898
+0.1%
1.47%
-26.7%
BuyCELGENE CORPcall$36,073,000
+426.2%
3,451
+396.5%
1.35%
+277.4%
REGN BuyREGENERON PHARMACEUTICALS INC$30,521,000
+22.2%
75,919
+6.1%
1.14%
-12.3%
NewBRISTOL MYERS SQUIBB CO.call$29,165,0005,409
+100.0%
1.09%
BuyALKERMES PLCcall$28,201,000
+255.6%
3,249
+143.4%
1.06%
+155.3%
NewMERCK & CO INCcall$28,003,0004,487
+100.0%
1.05%
BuyCELGENE CORPput$25,244,000
+3226.0%
2,415
+3036.4%
0.95%
+2265.0%
NewACADIA PHARMACEUTICALS INCcall$24,761,0007,784
+100.0%
0.93%
NewAGIOS PHARMACEUTICALS INCcall$21,698,0004,108
+100.0%
0.81%
BuyCLOVIS ONCOLOGY INCcall$21,089,000
+845.3%
5,850
+259.8%
0.79%
+581.0%
NewEXPRESS SCRIPTS HOLDING COcall$20,433,0002,897
+100.0%
0.77%
NewBRISTOL MYERS SQUIBB CO.put$18,705,0003,469
+100.0%
0.70%
BuyVERTEX PHARMACEUTICALS INCcall$17,050,000
+225.4%
1,955
+221.0%
0.64%
+134.1%
BuyCEMPRA INCput$15,302,000
+296.5%
6,323
+170.2%
0.57%
+185.1%
BuyPUMA BIOTECHNOLOGY INCcall$13,551,000
+893.5%
2,021
+341.3%
0.51%
+615.5%
NewUNITED THERAPEUTICS CORPput$12,965,0001,098
+100.0%
0.49%
BuySPDR SERIES TRUSTput$12,980,000
+29.2%
1,958
+5.4%
0.49%
-7.3%
NewHUMANA INCput$12,382,000700
+100.0%
0.46%
NewEXPRESS SCRIPTS HOLDING COput$11,927,0001,691
+100.0%
0.45%
NewASTRAZENECA PLCcall$11,567,0003,520
+100.0%
0.43%
BuyLEXICON PHARMACEUTICALS INCcall$11,317,000
+48.2%
6,263
+17.7%
0.42%
+6.5%
NewHESS CORPcall$11,040,0002,059
+100.0%
0.41%
BuyDEPOMED INCcall$10,798,000
+598.4%
4,321
+448.4%
0.40%
+400.0%
BuyALNYLAM PHARMACEUTICALS INCcall$9,815,000
+79.2%
1,448
+46.7%
0.37%
+28.7%
ONS BuyONCOBIOLOGICS INC$9,643,000
+37.1%
2,268,585
+9.6%
0.36%
-1.6%
NewBLUEBIRD BIO INCcall$9,354,0001,380
+100.0%
0.35%
BMY NewBRISTOL MYERS SQUIBB CO.$8,459,000156,887
+100.0%
0.32%
BuyDYNAVAX TECHNOLOGIES CORPput$8,002,000
-7.6%
7,628
+28.4%
0.30%
-33.6%
BuyCLOVIS ONCOLOGY INCput$7,538,000
+5246.1%
2,091
+1930.1%
0.28%
+3928.6%
BuyHORIZON PHARMA PLCcall$7,412,000
+104.1%
4,088
+85.4%
0.28%
+46.3%
BuyCEMPRA INCcall$7,306,000
+188.2%
3,019
+96.4%
0.27%
+107.6%
BuyACHILLION PHARMACEUTICALS INCcall$7,322,000
+145.3%
9,039
+136.2%
0.27%
+75.6%
BuyTENET HEALTHCARE CORPcall$7,204,000
+3116.1%
3,179
+3824.7%
0.27%
+2150.0%
BuyAMICUS THERAPEUTICS INCcall$7,128,000
+63.3%
9,632
+20.5%
0.27%
+17.1%
BuyOPHTHOTECH CORPcall$6,998,000
+279.9%
1,517
+320.2%
0.26%
+172.9%
NewEXELIXIS INCput$6,896,0005,392
+100.0%
0.26%
NewKITE PHARMA INCput$6,575,0001,177
+100.0%
0.25%
NewAXOVANT SCIENCES LTDcall$6,552,0004,680
+100.0%
0.24%
BuyLION BIOTECHNOLOGIES INCput$6,503,000
+6.7%
7,901
+5.0%
0.24%
-23.3%
BuyNEUROCRINE BIOSCIENCES INCcall$6,148,000
+66.4%
1,214
+49.3%
0.23%
+19.2%
NewGILEAD SCIENCES INCput$6,100,000771
+100.0%
0.23%
BuyKITE PHARMA INCcall$6,044,000
+42.0%
1,082
+27.1%
0.23%
+1.8%
SHPG BuySHIRE PLC$6,043,000
+11.1%
31,172
+5.5%
0.23%
-20.4%
BuyHALOZYME THERAPEUTICS INCcall$5,920,000
+226.5%
4,901
+133.3%
0.22%
+133.7%
BuyALNYLAM PHARMACEUTICALS INCput$5,890,000
+75.1%
869
+43.4%
0.22%
+26.3%
BuyPTC THERAPEUTICS INCcall$5,589,000
+357.7%
3,989
+129.3%
0.21%
+226.6%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$5,474,000
+29.2%
521,875
+79.6%
0.20%
-7.2%
BuyLA JOLLA PHARMACEUTICAL COcall$4,910,000
+110.5%
2,064
+41.6%
0.18%
+50.8%
NewHUMANA INCcall$4,918,000278
+100.0%
0.18%
BuyAERIE PHARMACEUTICALS INCcall$4,453,000
+275.5%
1,180
+75.1%
0.17%
+169.4%
CYTR NewCYTRX CORP.$4,368,0007,424,786
+100.0%
0.16%
NewSYNERGY PHARMACEUTICALS INC.call$4,360,0007,912
+100.0%
0.16%
BuyAMARIN CORPORATION PLCcall$4,354,000
+114.2%
13,648
+45.0%
0.16%
+53.8%
NewPUMA BIOTECHNOLOGY INCput$4,311,000643
+100.0%
0.16%
CELG NewCELGENE CORP$3,944,00037,728
+100.0%
0.15%
NewTENET HEALTHCARE CORPput$3,952,0001,744
+100.0%
0.15%
BuyMANNKIND CORPput$3,863,000
-78.9%
62,303
+17.6%
0.14%
-84.8%
BuyGW PHARMACEUTICALS PLCcall$3,624,000
+130.1%
273
+58.7%
0.14%
+65.9%
NewNOVO NORDISK A/Sput$3,573,000859
+100.0%
0.13%
OPGN BuyOPGEN INC.$3,545,000
+43.5%
2,161,467
+33.0%
0.13%
+3.1%
UTHR NewUNITED THERAPEUTICS CORP$3,319,00028,112
+100.0%
0.12%
EIGR BuyEIGER BIOPHARMACEUTICALS INC.$3,090,000
-11.0%
230,803
+31.7%
0.12%
-35.9%
TSRO NewTESARO INC$2,757,00027,500
+100.0%
0.10%
BuyOPKO HEALTH INCcall$2,638,000
+89.4%
2,491
+67.1%
0.10%
+35.6%
BuySANGAMO BIOSCIENCES INCcall$2,598,000
+2.0%
5,611
+27.5%
0.10%
-27.1%
THC NewTENET HEALTHCARE CORP$2,557,000112,831
+100.0%
0.10%
NewGW PHARMACEUTICALS PLCput$2,548,000192
+100.0%
0.10%
BuyREGENERON PHARMACEUTICALS INCcall$2,533,000
+68.6%
63
+46.5%
0.10%
+21.8%
BuyEXELIXIS INCcall$2,468,000
+77.2%
1,930
+8.2%
0.09%
+26.0%
BuyDERMIRA INCcall$2,442,000
+102.7%
722
+75.2%
0.09%
+44.4%
BuyHCA HOLDINGS INCput$2,390,000
+210.4%
316
+216.0%
0.09%
+125.0%
SPHS NewSOPHIRIS BIO INC.$2,354,000757,033
+100.0%
0.09%
BuyDERMIRA INCput$2,293,000
+171.4%
678
+134.6%
0.09%
+95.5%
NewENDO INTERNATIONAL PLCput$2,208,0001,096
+100.0%
0.08%
VXZ NewBARCLAYS BANK PLCipath$2,215,00065,000
+100.0%
0.08%
CDTX BuyCIDARA THERAPEUTICS INC.$2,180,000
+943.1%
190,358
+838.8%
0.08%
+645.5%
NewEXACT SCIENCES CORPput$2,137,0001,153
+100.0%
0.08%
VSAR NewVERSARTIS INC.$2,143,000174,968
+100.0%
0.08%
BuyINSMED INCcall$2,118,000
+59.6%
1,459
+8.4%
0.08%
+14.5%
NewSYNERGY PHARMACEUTICALS INC.put$2,117,0003,842
+100.0%
0.08%
RNN BuyREXAHN PHARMACEUTICALS INC$1,988,000
-12.8%
9,464,849
+4.3%
0.07%
-37.8%
NewPROTHENA CORPORATION PLCcall$1,949,000325
+100.0%
0.07%
ATNM NewACTINIUM PHARMACEUTICALS INC$1,867,0001,382,629
+100.0%
0.07%
EDIT NewEDITAS MEDICINE INC.$1,820,000135,000
+100.0%
0.07%
BuyINSMED INCput$1,811,000
+138.3%
1,247
+61.7%
0.07%
+70.0%
NTLA NewINTELLIA THERAPEUTICS INC$1,784,000104,841
+100.0%
0.07%
NewAGENUS INCput$1,795,0002,500
+100.0%
0.07%
NewACADIA PHARMACEUTICALS INCput$1,743,000548
+100.0%
0.06%
NewNEVRO CORPcall$1,681,000161
+100.0%
0.06%
BuyAMICUS THERAPEUTICS INCput$1,689,000
+38.4%
2,282
+2.1%
0.06%
-1.6%
HEB NewHEMISPHERX BIOPHARMA INC.$1,690,0001,351,850
+100.0%
0.06%
BuyGLOBAL BLOOD THERAPEUTICS INCcall$1,662,000
+138.1%
721
+71.3%
0.06%
+72.2%
CRME NewCARDIOME PHARMA CORP$1,521,000484,505
+100.0%
0.06%
RXDX BuyIGNYTA INC$1,421,000
+16.5%
225,900
+0.4%
0.05%
-17.2%
ONCS BuyONCOSEC MEDICAL INC$1,426,000
+43.0%
834,004
+37.2%
0.05%
+1.9%
ITEK BuyINOTEK PHARMACEUTICALS CORP$1,365,000
+72.3%
144,002
+35.3%
0.05%
+24.4%
BuyACHILLION PHARMACEUTICALS INCput$1,362,000
+74.6%
1,681
+68.1%
0.05%
+24.4%
MDGS NewMEDIGUS LTD$1,373,0001,042,813
+100.0%
0.05%
ONSIZ BuyONCOBIOLOGICS INC*w$1,332,000
+579.6%
926,651
+112.1%
0.05%
+400.0%
BuyTHERAPEUTICSMD INCcall$1,301,000
+32.8%
1,910
+65.7%
0.05%
-3.9%
DNAI BuyPRONAI THERAPEUTICS INC.$1,252,000
+6.6%
687,734
+16.6%
0.05%
-23.0%
BuyALCOBRA LTDcall$1,192,000
-40.6%
4,826
+8.0%
0.04%
-57.1%
CAPR BuyCAPRICOR THERAPEUTICS INC.$1,183,000
+64.5%
357,436
+96.3%
0.04%
+15.8%
BuyACORDA THERAPEUTICS INCput$1,176,000
+361.2%
563
+463.0%
0.04%
+238.5%
NewBIOCRYST PHARMACEUTICALS INCcall$1,140,0002,584
+100.0%
0.04%
CHEK NewCHECK CAP LTD$1,159,000585,569
+100.0%
0.04%
ONTXW NewONCONOVA THERAPEUTICS INC*w$1,124,000725,434
+100.0%
0.04%
MNKD NewMANNKIND CORP$1,107,0001,785,368
+100.0%
0.04%
IMUCWS NewIMMUNOCELLULAR THERAPEUTICS*w$1,077,00015,161,641
+100.0%
0.04%
STML NewSTEMLINE THERAPEUTICS INC$1,062,00098,050
+100.0%
0.04%
RIBT BuyRICEBRAN TECHNOLOGIES$1,073,000
-17.7%
794,436
+1.1%
0.04%
-41.2%
NewPACIRA PHARMACEUTICALS INCcall$1,057,000309
+100.0%
0.04%
CALA NewCALITHERA BIOSCIENCES INC.$1,055,000324,500
+100.0%
0.04%
BuyRADIUS HEALTH INCcall$1,055,000
+82.8%
195
+24.2%
0.04%
+33.3%
ONTX NewONCONOVA THERAPEUTICS INC$1,039,000392,023
+100.0%
0.04%
DRWIQ NewDRAGONWAVE INC.$1,018,000378,338
+100.0%
0.04%
ONSIW BuyONCOBIOLOGICS INC*w$905,000
+333.0%
902,050
+111.7%
0.03%
+209.1%
NSPRWS NewINSPIREMD INC*w$888,00029,594,500
+100.0%
0.03%
EYEG BuyEYEGATE PHARMACEUTICALS INC$834,000
-16.8%
508,598
+31.4%
0.03%
-40.4%
MDGN BuyMEDGENICS INC$791,000
+2.7%
141,977
+2.3%
0.03%
-25.0%
BuyRADIUS HEALTH INCput$763,000
+73.0%
141
+17.5%
0.03%
+26.1%
IMUC BuyIMMUNOCELLULAR THERAPEUTICS$756,000
-26.2%
6,405,230
+43.9%
0.03%
-47.2%
NewPORTOLA PHARMACEUTICALS INCcall$681,000300
+100.0%
0.03%
NewFOAMIX PHARMACEUTICALS LTDcall$670,000724
+100.0%
0.02%
BuyANTHERA PHARMACEUTICALS INCcall$668,000
+29.0%
2,121
+26.5%
0.02%
-7.4%
MRTX NewMIRATI THERAPEUTICS INC.$659,00099,735
+100.0%
0.02%
BuyARBUTUS BIOPHARMA CORPcall$670,000
+187.6%
1,949
+191.3%
0.02%
+108.3%
SCON NewSUPERCONDUCTOR TECHNOLOGIES INC.$669,000250,474
+100.0%
0.02%
BuyTENAX THERAPEUTICS INCcall$583,000
+577.9%
2,534
+656.4%
0.02%
+450.0%
NewBLUEPRINT MEDICINES CORPput$564,000190
+100.0%
0.02%
NewPACIRA PHARMACEUTICALS INCput$544,000159
+100.0%
0.02%
MDCO BuyMEDICINES CO$510,000
+117.0%
13,508
+93.0%
0.02%
+58.3%
NLNK BuyNEWLINK GENETICS CORP$519,000
+63.2%
34,561
+22.3%
0.02%
+11.8%
RNVA NewRENNOVA HEALTH INC$516,0002,724,721
+100.0%
0.02%
SSH NewSUNSHINE HEART INC.$518,000908,021
+100.0%
0.02%
NewTESARO INCput$501,00050
+100.0%
0.02%
NewCOMMUNITY HEALTH SYSTEMS INCput$477,000413
+100.0%
0.02%
NewINOTEK PHARMACEUTICALS CORPput$474,000500
+100.0%
0.02%
BuyBIODELIVERY SCIENCES INTERNATIONAL INCcall$478,000
+24.5%
1,770
+8.9%
0.02%
-10.0%
CMRX NewCHIMERIX INC.$443,00079,900
+100.0%
0.02%
CBMXW BuyCOMBIMATRIX CORP.*w$429,000
-25.1%
857,746
+0.3%
0.02%
-46.7%
NUROW BuyNEUROMETRIX INC*w$400,000
-34.6%
3,060,947
+0.0%
0.02%
-53.1%
NewLION BIOTECHNOLOGIES INCcall$408,000496
+100.0%
0.02%
NewFLEXION THERAPEUTICS INCput$395,000202
+100.0%
0.02%
AVXS NewAVEXIS ORD SHS$412,00010,000
+100.0%
0.02%
NewTHERAPEUTICSMD INCput$399,000586
+100.0%
0.02%
NewBENITEC BIOPHARMA LTDadr$385,000274,573
+100.0%
0.01%
NewACORDA THERAPEUTICS INCcall$374,000179
+100.0%
0.01%
NewFIBROGEN INCcall$339,000164
+100.0%
0.01%
CYH NewCOMMUNITY HEALTH SYSTEMS INC$359,00031,122
+100.0%
0.01%
BuyAMARIN CORPORATION PLCput$358,000
+48.5%
1,121
+0.3%
0.01%0.0%
NewINCYTE CORPcall$339,00036
+100.0%
0.01%
NURO BuyNEUROMETRIX INC$338,000
+18.2%
219,336
+27.3%
0.01%
-13.3%
NewANAVEX LIFE SCIENCES CORPput$311,000858
+100.0%
0.01%
NewMEDGENICS INCcall$297,000533
+100.0%
0.01%
DRNA NewDICERNA PHARMACEUTICALS INC$294,00050,000
+100.0%
0.01%
QRHC NewQUEST RESOURCE HOLDING CORP$281,000138,980
+100.0%
0.01%
RNVAW NewRENNOVA HEALTH INC*w$258,0003,682,014
+100.0%
0.01%
OCUL NewOCULAR THERAPEUTIX INC$262,00038,100
+100.0%
0.01%
NewSYNERGY PHARMACEUTICALS INC.*w$268,000348,743
+100.0%
0.01%
NewAETERNA ZENTARIS INCput$254,000740
+100.0%
0.01%
APOP NewCELLECT BIOTECHNOLOGY LTDads$264,00057,348
+100.0%
0.01%
NewSTEMLINE THERAPEUTICS INCcall$240,000222
+100.0%
0.01%
BuyDURECT CORPcall$245,000
+160.6%
1,759
+128.4%
0.01%
+80.0%
TXMD NewTHERAPEUTICSMD INC$232,00034,030
+100.0%
0.01%
BuyNATERA INCcall$161,000
-7.5%
145
+0.7%
0.01%
-33.3%
SGMO NewSANGAMO BIOSCIENCES INC$152,00032,804
+100.0%
0.01%
EVOK NewEVOKE PHARMA INC.$144,00063,768
+100.0%
0.01%
NewSORRENTO THERAPEUTICS INCcall$127,000164
+100.0%
0.01%
BuyALCOBRA LTDput$138,000
-25.0%
559
+36.7%
0.01%
-50.0%
BuyINVIVO THERAPEUTICS HOLDINGS CORPcall$135,000
+132.8%
199
+99.0%
0.01%
+66.7%
NewINOTEK PHARMACEUTICALS CORPcall$100,000106
+100.0%
0.00%
BuyATHERSYS INCput$101,000
+106.1%
476
+111.6%
0.00%
+33.3%
PVCT BuyPROVECTUS BIOPHARMACEUTICALS INC$107,000
+205.7%
1,077,555
+1055.1%
0.00%
+100.0%
NewGALECTIN THERAPEUTICS INCput$93,000825
+100.0%
0.00%
NewASTERIAS BIOTHERAPEUTICS INCcall$85,000200
+100.0%
0.00%
NSPR NewINSPIREMD INC$54,000679,224
+100.0%
0.00%
BuyEDAP TMS S Aput$53,000
+1.9%
182
+15.9%
0.00%
-33.3%
GALE BuyGALENA BIOPHARMA INC$49,000
-7.5%
141,000
+24.2%
0.00%
-33.3%
GPL NewGREAT PANTHER SILVER LTD$55,00040,450
+100.0%
0.00%
NewADAMIS PHARMACEUTICALS CORPput$51,000148
+100.0%
0.00%
BuyZAFGEN INCcall$15,000
-97.3%
2,149
+131.1%
0.00%
-96.6%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings